198HO02264 ECUADOR P

Print/PDF
Registration Name KNO ECUADOR P-ET
Registration Number HODEU000363306118
Primary NAAB Code 198HO02264
Secondary Code(s) 598HO02264
Status Foreign
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 8/28/2020
aAa 243165
DMS -
GFI 11%
Genetic Codes * PC TD TC TL TR TY TV TM TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHP-C
Sire PEAK ALTAHOTHAND-ET
MGS VEENHUIZER K L JT JAMESON
Beta Casein A2A2
Kappa Casein AA
Beta Lactoglobulin AB
INDEXES
NM$ 422, 79% R CM$ 441
NM Percentile 42% FM$ 379
GTPI 2934 GM$ 401
PRODUCTION TRAITS
321 Dtrs 97 herds 0 % US 88% R
Milk 1224 Fat, % 28 , -0.08%
SCS 2.92, 87% R Protein, % 49 , +0.03%
Feed Saved 247 , 50% R Milking Speed 6.62 , 64% R
Health & Fertility
Productive Life 1.1      82% R Mastitis -0.1      75% R
Heifer Livability 0.8       54% R Metritis 0.1      70% R
Livability -1.2      78% R D. Abom 0.0      73% R
DPR -1.8      85% R Ketosis 0.7      69% R
HCR -2.2      80% R R. Placenta -0.1      71% R
FSC -5.5      77% R Milk Fever -0.1      62% R
CCR -1.8      84% R
SCR -        -
DIA 0.4      40% R
RSP -0.1      48% R
Calving Traits
Sire CE 1.2      45% R 373 Obs
Daughter CE 1.6      31% R 0 Obs, 159 Dtrs
Sire SB 4.0      38% R 712 Obs
Daughter SB 4.9      38% R 0 Obs, Dtrs
Gestation Length -0.8      76% R 0 Obs, 0 Dtrs
Early First Calving -1.6      76% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
193 Dtrs 61 herds 87% R
PTA Type 0.79 UDC 1.06
HCC 1.94 BWC -1.67
FLC 0.79
Linear Traits
Stature -0.14
Short
Strength -0.99
Weak
Body Depth -0.38
Shallow
Dairy Form 2.02
Open
Rump Angle -0.16
Flat
Thurl Width 0.35
Wide
Rear Legs-Side View -0.14
Straight
Rear Legs-Rear View 0.99
Straight
Foot Angle 0.37
Steep
Feet & Legs Score 0.64
High
F.U. Attachment 0.53
Strong
Rear Udder Height 1.61
High
Rear Udder Width 1.71
Wide
Udder Cleft 0.83
Strong
Udder Depth 0.06
Shallow
Front Teat Placement 0.22
Close
Rear Teat Placement 0.44
Close
Teat Length -0.10
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO